Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
BMC
2024-10-01
|
| Collection: | Stem Cell Research & Therapy |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s13287-024-03961-4 |